| AD | Alzheimer’s disease |
| BBB | blood–brain barrier |
| B-CSF | Blood–cerebrospinal fluid |
| CM | cerebral malaria |
| CNS | central nervous system |
| DAMPs | damage-associated molecular pattern |
| DC | dendritic cell |
| EC | endothelial cell |
| ECM | experimental cerebral malaria |
| FL-IL-33 | full length Interleukin-33 |
| HCM | human cerebral malaria |
| ICH | intracranial hemorrhage |
| ILC2 | type-2 innate lymphoid cell |
| iRBC | infected red blood cell |
| LAP | LC3-Associated Phagocytosis |
| LC3 | Microtubule-associated protein 1A/1B-light chain 3 |
| MC | mast cells |
| MHC-I | major histocompatibility complex class I |
| mIL-33 | mature Interleukin-33 |
| MS | multiple sclerosis |
| PbA | Plasmodium berghei ANKA |
| PbA-MVs | parasite microvesicules |
| PfEMP1 | Plasmodium erythrocyte membrane protein 1 |
| TLRs | Toll-like-receptors |
| Tregs | regulatory T cells |